Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma

BACKGROUND AND OBJECTIVES: Cutaneous malignant melanoma arises from transformed melanocytes de novo or from congenital or acquired melanocytic nevi. We have recently reported that T-type Ca2+ channels (TTCs) are upregulated in human melanoma and play an important role on cell proliferation. The aim...

Descripción completa

Detalles Bibliográficos
Autores: Maiques Carlos, Oscar, Macià Armengol, Anna, Moreno, Sara, Barceló Gómez, Carla, Santacana Espasa, Maria, Veà Jódar, Àlvar, Herreros Danés, Judit, Gatius Calderó, Sònia, Ortega Izquierdo, Maria Eugenia, Valls Marsal, Joan, Chen, Bo-Juen, Llovet Navàs, David, Matias-Guiu, Xavier, Cantí Nicolás, Carles, Martí Laborda, Rosa Ma.
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2016
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10459.1/60518
Acceso en línea:https://doi.org/10.1111/bjd.15121
http://hdl.handle.net/10459.1/60518
Access Level:acceso abierto
Palabra clave:Melanoma
Immunohistoquímica
Canals de calci
Histopatologia
Immunohistochemistry
Calcium channels
Pathological histology
id ES_cf2a7cd91144df0aadd905449a08d7cf
oai_identifier_str oai:recercat.cat:10459.1/60518
network_acronym_str ES
network_name_str España
repository_id_str
spelling Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanomaMaiques Carlos, OscarMacià Armengol, AnnaMoreno, SaraBarceló Gómez, CarlaSantacana Espasa, MariaVeà Jódar, ÀlvarHerreros Danés, JuditGatius Calderó, SòniaOrtega Izquierdo, Maria EugeniaValls Marsal, JoanChen, Bo-JuenLlovet Navàs, DavidMatias-Guiu, XavierCantí Nicolás, CarlesMartí Laborda, Rosa Ma.MelanomaImmunohistoquímicaCanals de calciHistopatologiaMelanomaImmunohistochemistryCalcium channelsPathological histologyBACKGROUND AND OBJECTIVES: Cutaneous malignant melanoma arises from transformed melanocytes de novo or from congenital or acquired melanocytic nevi. We have recently reported that T-type Ca2+ channels (TTCs) are upregulated in human melanoma and play an important role on cell proliferation. The aim of this study was to describe for the first time in formalin-fixed-paraffin-embedded tissue the immunoexpression of TT-Cs in biopsies of normal skin, acquired melanocytic nevi and melanoma, in order to evaluate their role in melanomagenesis and/or tumor progression, their utility as prognostic markers and their possible use in targeted therapies. METHODS: Tissue samples from normal skin, melanocytic nevi and melanoma were subjected to immunohistochemistry for two TT-Cs (Cav3.1, Cav3.2), markers of proliferation (Ki67), cell cycle (Cyclin D1), hypoxia (Glut1), vascularization (CD31) and autophagy (LC3), V600E/BRAF mutation (VE-1) and PTEN. Immunostaining was evaluated by histoscore. In silico analysis was used to assess the prognostic value of TT-Cs over-expression. RESULTS: TT-Cs immunoexpression increased gradually from normal skin to common nevi, dysplastic nevi and melanoma samples, but with differences in distribution of both isoforms. Particularly, Cav3.2 expression was significantly higher in metastatic melanoma than in primary melanoma. Statistical correlation showed a lineal interaction between PTEN-loss/ V600E-BRAF/ Cav3.1/ LC3/ Ki67/ Cyclin D1/ Cav3.2 /Glut1. Disease-free survival (DFS) and global survival (OS) correlated inversely with over-expression of Cav3.2. DFS also correlated inversely with over-expresion of Cav3.1. DISCUSSION: TT-Cs immunoexpression on melanocytic neoplasms 1) is consistent with our previous in vitro studies, 2) appears related to tumor progression, and 3) TT-Cs upregulation can be considered as a prognostic marker using TCGA database. The high expression of Cav3.2 in metastatic melanoma encourages the investigation of the use of TT-Cs blockers in targeted therapies. This article is protected by copyright. All rights reserved.This study was supported by grants from ISCIII (FIS-PI1200260 to R.M.M., FIS-PI1301980 to J.H. and RETICS-RD12/0036/0013 to X.M.G.); from Fundació la Marató de TV3 (FMTV 201331-31 to R.M.M.) and from Generalitat de Catalunya (2014/SGR138 to X.M.-G.) and was cofinanced by FEDER ‘Una manera de hacer Europa’. O.M. and C.B. hold predoctoral fellowships from the University of Lleida and S.M. a predoctoral fellowship from IRBLleida/Diputació de Lleida. Tumour samples were obtained with the support of Xarxa de Bancs de Tumors de Catalunya, sponsored by Pla Director d'Oncología de Catalunya (XBTC), IRBLleida Biobank (B.0000682) and PLATAFORMA BIOBANCOS (PT13/0010/0014)Wiley Online Library2017201820162017info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttps://doi.org/10.1111/bjd.15121http://hdl.handle.net/10459.1/60518http://hdl.handle.net/10459.1/60518reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésVersió postprint del document publicat a: https://doi.org/10.1111/bjd.15121British Journal of Dermatology, 2016, vol. 176, num. 5, p. 1247-1258(c) British Association of Dermatologists, 2016info:eu-repo/semantics/openAccessoai:recercat.cat:10459.1/605182026-05-29T05:05:01Z
dc.title.none.fl_str_mv Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma
title Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma
spellingShingle Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma
Maiques Carlos, Oscar
Melanoma
Immunohistoquímica
Canals de calci
Histopatologia
Melanoma
Immunohistochemistry
Calcium channels
Pathological histology
title_short Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma
title_full Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma
title_fullStr Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma
title_full_unstemmed Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma
title_sort Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma
dc.creator.none.fl_str_mv Maiques Carlos, Oscar
Macià Armengol, Anna
Moreno, Sara
Barceló Gómez, Carla
Santacana Espasa, Maria
Veà Jódar, Àlvar
Herreros Danés, Judit
Gatius Calderó, Sònia
Ortega Izquierdo, Maria Eugenia
Valls Marsal, Joan
Chen, Bo-Juen
Llovet Navàs, David
Matias-Guiu, Xavier
Cantí Nicolás, Carles
Martí Laborda, Rosa Ma.
author Maiques Carlos, Oscar
author_facet Maiques Carlos, Oscar
Macià Armengol, Anna
Moreno, Sara
Barceló Gómez, Carla
Santacana Espasa, Maria
Veà Jódar, Àlvar
Herreros Danés, Judit
Gatius Calderó, Sònia
Ortega Izquierdo, Maria Eugenia
Valls Marsal, Joan
Chen, Bo-Juen
Llovet Navàs, David
Matias-Guiu, Xavier
Cantí Nicolás, Carles
Martí Laborda, Rosa Ma.
author_role author
author2 Macià Armengol, Anna
Moreno, Sara
Barceló Gómez, Carla
Santacana Espasa, Maria
Veà Jódar, Àlvar
Herreros Danés, Judit
Gatius Calderó, Sònia
Ortega Izquierdo, Maria Eugenia
Valls Marsal, Joan
Chen, Bo-Juen
Llovet Navàs, David
Matias-Guiu, Xavier
Cantí Nicolás, Carles
Martí Laborda, Rosa Ma.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Melanoma
Immunohistoquímica
Canals de calci
Histopatologia
Melanoma
Immunohistochemistry
Calcium channels
Pathological histology
topic Melanoma
Immunohistoquímica
Canals de calci
Histopatologia
Melanoma
Immunohistochemistry
Calcium channels
Pathological histology
description BACKGROUND AND OBJECTIVES: Cutaneous malignant melanoma arises from transformed melanocytes de novo or from congenital or acquired melanocytic nevi. We have recently reported that T-type Ca2+ channels (TTCs) are upregulated in human melanoma and play an important role on cell proliferation. The aim of this study was to describe for the first time in formalin-fixed-paraffin-embedded tissue the immunoexpression of TT-Cs in biopsies of normal skin, acquired melanocytic nevi and melanoma, in order to evaluate their role in melanomagenesis and/or tumor progression, their utility as prognostic markers and their possible use in targeted therapies. METHODS: Tissue samples from normal skin, melanocytic nevi and melanoma were subjected to immunohistochemistry for two TT-Cs (Cav3.1, Cav3.2), markers of proliferation (Ki67), cell cycle (Cyclin D1), hypoxia (Glut1), vascularization (CD31) and autophagy (LC3), V600E/BRAF mutation (VE-1) and PTEN. Immunostaining was evaluated by histoscore. In silico analysis was used to assess the prognostic value of TT-Cs over-expression. RESULTS: TT-Cs immunoexpression increased gradually from normal skin to common nevi, dysplastic nevi and melanoma samples, but with differences in distribution of both isoforms. Particularly, Cav3.2 expression was significantly higher in metastatic melanoma than in primary melanoma. Statistical correlation showed a lineal interaction between PTEN-loss/ V600E-BRAF/ Cav3.1/ LC3/ Ki67/ Cyclin D1/ Cav3.2 /Glut1. Disease-free survival (DFS) and global survival (OS) correlated inversely with over-expression of Cav3.2. DFS also correlated inversely with over-expresion of Cav3.1. DISCUSSION: TT-Cs immunoexpression on melanocytic neoplasms 1) is consistent with our previous in vitro studies, 2) appears related to tumor progression, and 3) TT-Cs upregulation can be considered as a prognostic marker using TCGA database. The high expression of Cav3.2 in metastatic melanoma encourages the investigation of the use of TT-Cs blockers in targeted therapies. This article is protected by copyright. All rights reserved.
publishDate 2016
dc.date.none.fl_str_mv 2016
2017
2017
2018
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.1111/bjd.15121
http://hdl.handle.net/10459.1/60518
http://hdl.handle.net/10459.1/60518
url https://doi.org/10.1111/bjd.15121
http://hdl.handle.net/10459.1/60518
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: https://doi.org/10.1111/bjd.15121
British Journal of Dermatology, 2016, vol. 176, num. 5, p. 1247-1258
dc.rights.none.fl_str_mv (c) British Association of Dermatologists, 2016
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) British Association of Dermatologists, 2016
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley Online Library
publisher.none.fl_str_mv Wiley Online Library
dc.source.none.fl_str_mv reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869420058008092672
score 15,812429